Target intelligence / Profile preview

DNA-directed RNA polymerase II subunit RPB2 (POLR2B)

Target
POLR2B
Molecular classification
Enzyme, Transcription factor (subunit of large transcription enzyme complex)
01

Overview

DNA-directed RNA polymerase II subunit RPB2 (POLR2B) is the **second largest subunit of RNA polymerase II**, a multiprotein enzyme complex that catalyzes the transcription of DNA into precursors of messenger RNA (mRNA), small nuclear RNA (snRNA), and microRNA in eukaryotic cells[1][2][3][5]. POLR2B associates with other core subunits to form the active site of the polymerase, participating in the catalysis of RNA synthesis by appending nucleotides and supporting transcription fidelity, including 3'-5' exonuclease proofreading activity[2][5]. Proper POLR2B function is required for all gene expression, making it fundamental to cell viability, and alterations or dysregulation of its activity are implicated in various diseases with transcriptional disturbances, such as cancer and viral infections[2][5]. Because it is vital for general gene transcription, POLR2B is not considered a typical small-molecule drug target, and attempts to therapeutically inhibit its function would have profound toxicity.

Other names
DNA-directed RNA polymerase II subunit BRNA polymerase II subunit BRPB2RNA polymerase II subunit 2RNA polymerase II subunit B2RNA-directed RNA polymerase II subunit RPB23'-5' exoribonucleaseDNA-directed RNA polymerase II 140 kDa polypeptide
02

Biological functions

Transcription of DNA to mRNATranscription of small nuclear RNA (snRNA)Transcription of microRNA (miRNA)Formation of the core catalytic site for RNA synthesis3'-5' exonuclease proofreading activity
03

Disease associations

Cancer (implicated via transcription dysregulation)Neurodegenerative disease (implicated via transcription dysregulation)HIV infection (involved in HIV transcriptional regulation)Fungal and skin infections (e.g., eumycotic mycetoma, tinea nigra per reported associations)
04

Safety considerations

Essential for gene expression in all eukaryotic cells (thus, inhibition causes severe toxicity)Targeting likely disrupts global gene transcription, leading to cell death and systemic toxicity

Beyond the preview

Go deeper on DNA-directed RNA polymerase II subunit RPB2 (POLR2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase II subunit RPB2 (POLR2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call